{"id":617186,"title":"Summary of Annex 3B to the Good manufacturing practices guide – Positron-emitting radiopharmaceuticals - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-03","captureTimestamp":"2026-03-03T04:41:29.985000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/annex-manufacturing-practices-positiron-emitting-radiopharmaceuticals.html","snippet":"Summary of Annex 3B to the Good manufacturing practices guide – Positron-emitting radiopharmaceuticals Good manufacturing practices guide for drug products (GUI-0001) Good Manufacturing Practices (GMP) for Active Pharmaceutical Ingredients (API) - (GUI-0104) Annex 3A to the Good…","rawSnapshotUrl":"/api/snapshots/raw/617186","browseUrl":"https://replay.healtharchive.ca/job-6/20260303044129/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/annex-manufacturing-practices-positiron-emitting-radiopharmaceuticals.html#ha_snapshot=617186","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}